A novel classification for IgA nephropathy

Slides:



Advertisements
Similar presentations
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Advertisements

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Volume 92, Issue 4, Pages (October 2017)
Volume 76, Issue 5, Pages (September 2009)
Volume 80, Issue 10, Pages (November 2011)
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 69, Pages S11-S15 (April 2006)
End-stage renal disease in living kidney donors
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
How to interpret the eGFR in patients with small body surface area
Volume 79, Issue 5, Pages (March 2011)
Comorbidity and confounding in end-stage renal disease
Volume 70, Issue 11, Pages (December 2006)
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Predicting an allograft's fate
Volume 85, Issue 6, Pages (June 2014)
U-shaped effect of eGFR and mortality
Volume 76, Issue 10, Pages (November 2009)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Volume 67, Pages S48-S51 (January 2005)
Volume 76, Issue 5, Pages (September 2009)
Fructose intake as a risk factor for kidney stone disease
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
Volume 85, Issue 3, Pages (March 2014)
Volume 76, Issue 3, Pages (August 2009)
Extracorporeal therapy in sepsis: are we there yet?
Volume 85, Issue 5, Pages (May 2014)
Methods for guideline development
Validation of the Oxford classification of IgA nephropathy
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
IgA nephropathy at two score and one
Racial disparities in access to transplantation: a tough nut to crack
Volume 76, Issue 8, Pages (October 2009)
Atrial fibrillation in end-stage renal disease: an emerging problem
The global challenge of chronic kidney disease
Volume 74, Issue 5, Pages (September 2008)
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Volume 85, Issue 5, Pages (May 2014)
Volume 81, Issue 9, Pages (May 2012)
Prehypertension: is it relevant for nephrologists?
Volume 78, Issue 5, Pages (September 2010)
Volume 82, Issue 7, Pages (October 2012)
Volume 77, Issue 12, Pages (June 2010)
Volume 74, Issue 9, Pages (November 2008)
Volume 60, Issue 1, Pages (July 2001)
Volume 76, Issue 6, Pages (September 2009)
Volume 80, Issue 10, Pages (November 2011)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Is it the low-protein diet or simply the salt restriction?
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Membranous nephropathy: recent travels and new roads ahead
Adiponectin: good, bad, or just plain ugly?
Volume 88, Issue 5, Pages (November 2015)
Volume 83, Issue 5, Pages (May 2013)
Volume 53, Issue 5, Pages (May 1998)
Volume 80, Issue 9, Pages (November 2011)
Prediction in idiopathic membranous nephropathy
Volume 78, Issue 5, Pages (September 2010)
Volume 79, Issue 10, Pages (May 2011)
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

A novel classification for IgA nephropathy Ryohei Yamamoto, Enyu Imai  Kidney International  Volume 76, Issue 5, Pages 477-480 (September 2009) DOI: 10.1038/ki.2009.206 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Strategy to develop the Oxford classification of IgA nephropathy. The Oxford classification was developed in two steps from 265 cases of IgA nephropathy with proteinuria greater than 0.5g/d and estimated glomerular filtration rate (eGFR) at least 30ml/min/1.73m2, followed for at least 1 year. First, to create the reproducible classification, the group refined the pathological scoring system by evaluating 265 renal biopsy samples from eight countries. Intraclass correlation coefficients were used for evaluation of the reproducibility of the scoring system. Seven pathological lesions were highly reproducible and can be used for classification of IgA nephropathy. Second, the pathological findings that represented independent risk factors for progression of IgA nephropathy were analyzed by multivariate models. *Excluded in the subsequent analyses because of high correlation coefficient with interstitial fibrosis/tubular atrophy and susceptibility to sampling error. **Endocapillary proliferative lesions were not significantly predictive of the rate of eGFR decline or of a 50% decrease in eGFR/ESRD. ESRD, end-stage renal disease. Kidney International 2009 76, 477-480DOI: (10.1038/ki.2009.206) Copyright © 2009 International Society of Nephrology Terms and Conditions